neominophagen c has been researched along with Cancer of Liver in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Imazeki, F | 1 |
| Yamada, G | 1 |
| Bi, MR; Chen, LY; Ma, YJ; Wang, Y; Yang, BS | 1 |
2 review(s) available for neominophagen c and Cancer of Liver
| Article | Year |
|---|---|
[Alternative measures for patients with chronic hepatitis C unresponsive to interferon therapy].
Topics: Antiviral Agents; Carcinoma, Hepatocellular; Clinical Trials as Topic; Cysteine; Drug Combinations; Drug Therapy, Combination; Genotype; Glycine; Hepacivirus; Hepatitis C, Chronic; Humans; Interferons; Iron, Dietary; Liver Neoplasms; Oleanolic Acid; Phlebotomy; Prognosis; Ribavirin; Time Factors | 2004 |
[Clinical aspects of type-C cirrhosis of liver--diagnosis, clinical course, treatment and prognosis].
Topics: Antiviral Agents; Carcinoma, Hepatocellular; Cysteine; Disease Progression; Drug Combinations; Drug Therapy, Combination; Fibrosis; Glycine; Hepatitis C, Chronic; Humans; Interferons; Liver; Liver Cirrhosis; Liver Neoplasms; Oleanolic Acid; Prognosis; Ribavirin; Risk; Ursodeoxycholic Acid | 2004 |
1 other study(ies) available for neominophagen c and Cancer of Liver
| Article | Year |
|---|---|
[Molecular mechanisms of the protection of SNMC in HepG2 cell apoptosis].
Topics: Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cysteine; Drug Combinations; Glycine; Glycyrrhiza; Humans; Liver Neoplasms; Oleanolic Acid | 2005 |